Cargando…
Cystic metastasis of prostate cancer: A case report
RATIONALE: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accura...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320181/ https://www.ncbi.nlm.nih.gov/pubmed/30558081 http://dx.doi.org/10.1097/MD.0000000000013697 |
_version_ | 1783385189701910528 |
---|---|
author | Zhang, Bei Bian, Bingyang Bi, Lirong Wang, Zhuo Zhao, Yang Wang, Jiping |
author_facet | Zhang, Bei Bian, Bingyang Bi, Lirong Wang, Zhuo Zhao, Yang Wang, Jiping |
author_sort | Zhang, Bei |
collection | PubMed |
description | RATIONALE: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accurate identification of cystic metastasis can be helpful in management of prostate cancer. PATIENT CONCERNS: A 64-year-old male was admitted to our hospital due to urethral irritation symptom and dysuria. DIAGNOSIS: In addition to prostate cancer, abdominal computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the prostate revealed that a cystic mass was located at right pelvic cavity. Histopathological examination diagnosed the pelvic cystic mass as metastasis from prostatic cancer. Immunohistochemistry results demonstrated Calretinin (+), D2-40 (−), Ki-67 (10%+), Vimentin (−), CK-pan (+), CK5/6 (−), WT-1 (−), PSA (+), SALL4 (−), Villin (−), CK20 (−), CK7 (−), PAX-8 (−), and TTF-1 (−). INTERVENTIONS: The cystic mass was removed. Primary cancer of the prostate was reserved as well. After discharge, the patient underwent in a two-year androgen deprivation therapy (ADT) treatment. OUTCOMES: After 13 months of discharge, no disease progression was found in the patient. LESSONS: Although cystic prostate cancer is rare, the occurrence possibility should be considered when cystic lesions are accompanied with prostate cancer. |
format | Online Article Text |
id | pubmed-6320181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-63201812019-01-14 Cystic metastasis of prostate cancer: A case report Zhang, Bei Bian, Bingyang Bi, Lirong Wang, Zhuo Zhao, Yang Wang, Jiping Medicine (Baltimore) Research Article RATIONALE: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accurate identification of cystic metastasis can be helpful in management of prostate cancer. PATIENT CONCERNS: A 64-year-old male was admitted to our hospital due to urethral irritation symptom and dysuria. DIAGNOSIS: In addition to prostate cancer, abdominal computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the prostate revealed that a cystic mass was located at right pelvic cavity. Histopathological examination diagnosed the pelvic cystic mass as metastasis from prostatic cancer. Immunohistochemistry results demonstrated Calretinin (+), D2-40 (−), Ki-67 (10%+), Vimentin (−), CK-pan (+), CK5/6 (−), WT-1 (−), PSA (+), SALL4 (−), Villin (−), CK20 (−), CK7 (−), PAX-8 (−), and TTF-1 (−). INTERVENTIONS: The cystic mass was removed. Primary cancer of the prostate was reserved as well. After discharge, the patient underwent in a two-year androgen deprivation therapy (ADT) treatment. OUTCOMES: After 13 months of discharge, no disease progression was found in the patient. LESSONS: Although cystic prostate cancer is rare, the occurrence possibility should be considered when cystic lesions are accompanied with prostate cancer. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320181/ /pubmed/30558081 http://dx.doi.org/10.1097/MD.0000000000013697 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Research Article Zhang, Bei Bian, Bingyang Bi, Lirong Wang, Zhuo Zhao, Yang Wang, Jiping Cystic metastasis of prostate cancer: A case report |
title | Cystic metastasis of prostate cancer: A case report |
title_full | Cystic metastasis of prostate cancer: A case report |
title_fullStr | Cystic metastasis of prostate cancer: A case report |
title_full_unstemmed | Cystic metastasis of prostate cancer: A case report |
title_short | Cystic metastasis of prostate cancer: A case report |
title_sort | cystic metastasis of prostate cancer: a case report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320181/ https://www.ncbi.nlm.nih.gov/pubmed/30558081 http://dx.doi.org/10.1097/MD.0000000000013697 |
work_keys_str_mv | AT zhangbei cysticmetastasisofprostatecanceracasereport AT bianbingyang cysticmetastasisofprostatecanceracasereport AT bilirong cysticmetastasisofprostatecanceracasereport AT wangzhuo cysticmetastasisofprostatecanceracasereport AT zhaoyang cysticmetastasisofprostatecanceracasereport AT wangjiping cysticmetastasisofprostatecanceracasereport |